Emerging Infectious Diseases of the 21st Century – serie

This volume provides the specialist and trainee in microbiology, infectious disease, infection control, and epidemiology with a concise and authoritative review of some of the most problematic infections of the new century. This volume should foster a better understanding of the issues and new ideas for preventing and controlling infectious disease.

The main purpose of Genomic and Computational Tools for Infectious Diseases is to systematically present to the reader with a description and review of the principles, methodology, applications, and challenges related with the use of genomic tools to study influenza, HIV, encephalic and hemorrhagic viruses, malaria, and tuberculosis. This book will compile a comprehensive overview of the application of computational technologies to understand the biocomplexity of new and reemerging infectious diseases. The intent of this book is not to exhaustively survey the published literature on microbial functional genomics or bioinformatic tools, but rather, to provide the reader with representative examples and an illustrative guide of basic principles, approaches, and applications in genomics and computational biology specifically applied to specific pathogens. The book will include documents written by seasoned international researchers with extensive experience in both industry and academia. Each chapter will effectively outline the use of genomics for diagnostics, to study key aspects of the biology of a particular pathogen and its interaction with the host. Topics will include large scale sequencing, transcriptional analysis, regulatory element interactions and structural analysis of pathogen proteins and RNA interference. Another purpose of this book is to show the reader the advantages and limitations of recently developed high-throughput genomic and bioinformatic technologies. The book concludes with two chapters related to the use of nanobiotechnology and synthetic biology and their implications in the discovery, diagnostics and therapeutics. Numerous exercises for self-study as well as data sets and a useful collection of computational tools on the authors Web site will make this book a valuable resource for both students and professionals in the field.

This volume in the series Emerging Infectious Diseases of the 21st Century provides the most up-to-date and comprehensive information available on Bioterrorism agents such as - Anthrax, Smallpox, Plague, and SARS Vaccine Development New Anti-Viral Drug Development Treatment and Protection Threat Analysis and Response Biological and Chemical Agents Compiled by two of the leading experts in the field, Bioterrorism and Infectious Agents provides the specialist and trainee in microbiology, infectious disease, infection control, and epidemiology with a concise, timely, and authoritative review of some of the most problematic infections of the new century. This volume will foster a better understanding of the issues and new ideas for preventing and controlling infectious diseases.

This book was originally conceived at a conference at the University of Turin in Italy. The conference was organized to examine the so-called “Malaria Hypothesis”, that is to say, the higher fitness of t- lassemia heterozygotes in a malarial environment, and to pay tribute to the proponent of that hypothesis, J.B.S. Haldane. Contributors to this book examine certain genetic and evolutionary aspects of malaria which is a major killer of human populations, especially in Africa and Asia. There were attempts to discredit Haldane’s contribution from two directions: (a) it has been suggested that the “Malaria Hypothesis” was known long before Haldane and that there was nothing original about his idea (Lederberg 1999), and that (b) the hypothesis of heterozygote su- riority was first suggested by the Italian biologist Giuseppe Montalenti who communicated his idea to Haldane (Allison 2004). Surely, both c- not be right. In fact, the evidence presented in this book clearly indicates that both are wrong. Haldane’s malaria hypothesis has stimulated a great deal of research on the genetic, evolutionary and epidemiological aspects of malaria d- ing the last 50 years. It has opened up a whole new chapter in the study of infectious diseases. It deserves serious consideration. For helpful discussions we thank Lucio Luzzatto, Alberto Piazza, Guido Modiano and David Roberts.

Infectious diseases caused by bacterial pathogens are a leading cause of human illness and death worldwide. The study of bacterial pathogenesis has changed dramatically over the last decade, as a result of revolutionary changes in biotechnology and our understanding of molecular and cellular biological systems. This volume is structured to emphasize paradigms of infectious disease that have emerged over the last 10 years and provides a fundamental understanding of the complex cellular and molecular processes that are important for bacterial virulence and the infectious disease process. The book highlights key techniques and methodologies that have driven recent discoveries in bacterial pathogenesis, major structures and mechanisms in bacteria that are important for their pathogenesis, the regulation of these virulence determinants by global regulators, and bacterial biowarfare agents.

The past decade has been highlighted by numerous advances in research of medical scientific knowledge, medical technology and the biological and diagnostic techniques-but somewhat less dramatic changes or improvement in management of medical conditions. This volume in the Emerging Infectious Disease of the 21st century series, addresses some of the emerging issues and controversies in Infectious Diseases.The author has chosen these topics for review based on questions and contentions raised by medical residents, internists, emergency physicians, clinical infectious disease specialists and family physicians. This volume will provide guidance and answers to frequently asked questions in infectious diseases to the researcher, clinician, generalists, specialists and trainees in these areas; thus, facilitating improved patient care, prudent and cost effective management and investigation of these disorders.This volume reviews the research, diagnosis, and treatment of some common infections facing researchers, clinicians and family physicians such as sinusitis, otitis media and asymptomatic bacteriuria. Recent studies and surveys have shown that these conditions are often over diagnosed and treated unnecessarily with antibiotics. The approach and guidelines for diagnosis and management are reviewed in this volume. Other more complicated but less common conditions challenging internists, clinical infectious disease consultants and other specialists are also reviewed (i.e. meningitis, ventilator associated pneumonia, sepsis, hepatitis C, B etc.)

West Nile virus is a neurotropic flavivirus that has emerged globally as a primary cause of viral encephalitis. Infection of humans and other vertebrate animals is associated with a febrile illness that can progress to a lethal encephalitis or flaccid paralysis syndrome. Its appearance in the Western Hemisphere in 1999 and the corresponding increase in global disease burden over the last decade have been accompanied by intensive study, including the entry of many scientists into the field. Breakthroughs have been made in understanding the unique transmission pattern between the vector and the multiple avian and mammalian hosts and targets. Studies in mammalian systems have dissected the viral and host factors that determine the pathogenesis and outcome of West Nile virus infection. On the basis of these experiments, progress has been made on the identification of genetic factors that predispose to severe human disease. Thus, in a remarkably short period of time, insight has been gained on a wide variety of disciplines related to West Nile virus biology. The aim of this book was to assemble an up-to-date and cutti- edge anthology from the leading experts in the field. The chapters are balanced by submissions from newcomers who have made significant recent contributions with those from established investigators who have dedicated their careers to the study of West Nile virus.

In this edition of the Emerging Infectious Diseases of the 21st Century Series, the editor reviews the research, diagnosis, and treatment of some common infections facing researchers, clinicians and family physicians such as sinusitis, otitis media and pertussis in adults. Recent studies and surveys have shown that these conditions are often over diagnosed and treated unnecessarily with antibiotics. The approach and guidelines for diagnosis and management are reviewed in this volume. Other more complicated but less common conditions challenging internists, clinical infectious disease consultants and other specialists are also reviewed (i.e. meningitis, ventilator associated pneumonia, sepsis, hepatitis C, B, etc.).

Since the terrorist attack on the United States on September 11, 2001 and subsequent cases of anthrax in Florida and New York City, attention has been focused on the threat of b- logical warfare and bioterrorism. Biological warfare agents are de?ned as “living org- isms, whatever their nature, or infected material derived from them, which are used for h- tile purposes and intended to cause disease or death in man, animals and plants, and depend for their efforts on the ability to multiply in person, animal or plant attacked.” Biological warfare agents may be well suited for bioterrorism to create havoc and terror in a civilian population, because they are cheap and easy to obtain and dispense. Infectious or contagious diseases have played a major part in the history of warfare – deliberately or inadvertently – in restricting or assisting invading armies over the centuries. In 1346, the Tartars catapulted plaque-infected bodies into Kaffa in the Crimea to end a 3-year siege. Blankets contaminated with smallpox to infect North American Indians were used by British forces in the 18th century. More recently, the Japanese released ?eas infected with plaque in Chinese cities in the 1930s and 1940s. Biological research programs for both offensive and defensive strategies have been developed by the United States, Britain, the former Soviet Union, and Canada; several other nations are thought to have such programs.

This book was originally conceived at a conference at the University of Turin in Italy. The conference was organized to examine the so-called “Malaria Hypothesis”, that is to say, the higher fitness of t- lassemia heterozygotes in a malarial environment, and to pay tribute to the proponent of that hypothesis, J.B.S. Haldane. Contributors to this book examine certain genetic and evolutionary aspects of malaria which is a major killer of human populations, especially in Africa and Asia. There were attempts to discredit Haldane’s contribution from two directions: (a) it has been suggested that the “Malaria Hypothesis” was known long before Haldane and that there was nothing original about his idea (Lederberg 1999), and that (b) the hypothesis of heterozygote su- riority was first suggested by the Italian biologist Giuseppe Montalenti who communicated his idea to Haldane (Allison 2004). Surely, both c- not be right. In fact, the evidence presented in this book clearly indicates that both are wrong. Haldane’s malaria hypothesis has stimulated a great deal of research on the genetic, evolutionary and epidemiological aspects of malaria d- ing the last 50 years. It has opened up a whole new chapter in the study of infectious diseases. It deserves serious consideration. For helpful discussions we thank Lucio Luzzatto, Alberto Piazza, Guido Modiano and David Roberts.

The past decade has been highlighted by numerous advances in research of medical scientific knowledge, medical technology and the biological and diagnostic techniques-but somewhat less dramatic changes or improvement in management of medical conditions. This volume in the Emerging Infectious Disease of the 21st century series, addresses some of the emerging issues and controversies in Infectious Diseases.The author has chosen these topics for review based on questions and contentions raised by medical residents, internists, emergency physicians, clinical infectious disease specialists and family physicians. This volume will provide guidance and answers to frequently asked questions in infectious diseases to the researcher, clinician, generalists, specialists and trainees in these areas; thus, facilitating improved patient care, prudent and cost effective management and investigation of these disorders.This volume reviews the research, diagnosis, and treatment of some common infections facing researchers, clinicians and family physicians such as sinusitis, otitis media and asymptomatic bacteriuria. Recent studies and surveys have shown that these conditions are often over diagnosed and treated unnecessarily with antibiotics. The approach and guidelines for diagnosis and management are reviewed in this volume. Other more complicated but less common conditions challenging internists, clinical infectious disease consultants and other specialists are also reviewed (i.e. meningitis, ventilator associated pneumonia, sepsis, hepatitis C, B etc.)

In this edition of the Emerging Infectious Diseases of the 21st Century Series, the editor reviews the research, diagnosis, and treatment of some common infections facing researchers, clinicians and family physicians such as sinusitis, otitis media and pertussis in adults. Recent studies and surveys have shown that these conditions are often over diagnosed and treated unnecessarily with antibiotics. The approach and guidelines for diagnosis and management are reviewed in this volume. Other more complicated but less common conditions challenging internists, clinical infectious disease consultants and other specialists are also reviewed (i.e. meningitis, ventilator associated pneumonia, sepsis, hepatitis C, B, etc.).

Infectious diseases caused by bacterial pathogens are a leading cause of human illness and death worldwide. The study of bacterial pathogenesis has changed dramatically over the last decade, as a result of revolutionary changes in biotechnology and our understanding of molecular and cellular biological systems. This volume is structured to emphasize paradigms of infectious disease that have emerged over the last 10 years and provides a fundamental understanding of the complex cellular and molecular processes that are important for bacterial virulence and the infectious disease process. The book highlights key techniques and methodologies that have driven recent discoveries in bacterial pathogenesis, major structures and mechanisms in bacteria that are important for their pathogenesis, the regulation of these virulence determinants by global regulators, and bacterial biowarfare agents.

The aim of this book is not to encourage defensive medical practice, but to help provide better, optimum care to patients and to be forth right and honest to our dear customers about our inevitable mistakes.This book will focus on clinical issues facing physicians in different settings (which can lead to malpractice), and the best approach to use to avoid litigations, and practice good medicine.

The aim of this book is not to encourage defensive medical practice, but to help provide better, optimum care to patients and to be forth right and honest to our dear customers about our inevitable mistakes.This book will focus on clinical issues facing physicians in different settings (which can lead to malpractice), and the best approach to use to avoid litigations, and practice good medicine.

This next volume in the series will provide up to date Information and discussion on future approach to control several challenging Infectious Disease worldwide. The past decade has been highlighted by numerous advances in research of medical scientific knowledge. medical technology and the biological and diagnostic techniques-but somewhat less dramatic changes or improvement in management of medical conditions. This volume will address some of the emerging issues, challenges, and controversies in Infectious Diseases.

West Nile virus is a neurotropic flavivirus that has emerged globally as a primary cause of viral encephalitis. Infection of humans and other vertebrate animals is associated with a febrile illness that can progress to a lethal encephalitis or flaccid paralysis syndrome. Its appearance in the Western Hemisphere in 1999 and the corresponding increase in global disease burden over the last decade have been accompanied by intensive study, including the entry of many scientists into the field. Breakthroughs have been made in understanding the unique transmission pattern between the vector and the multiple avian and mammalian hosts and targets. Studies in mammalian systems have dissected the viral and host factors that determine the pathogenesis and outcome of West Nile virus infection. On the basis of these experiments, progress has been made on the identification of genetic factors that predispose to severe human disease. Thus, in a remarkably short period of time, insight has been gained on a wide variety of disciplines related to West Nile virus biology. The aim of this book was to assemble an up-to-date and cutti- edge anthology from the leading experts in the field. The chapters are balanced by submissions from newcomers who have made significant recent contributions with those from established investigators who have dedicated their careers to the study of West Nile virus.

Infectious agents have been recognized to involve the heart and vascular system for well over a century. Traditional concepts and teachings of their involvement in the pathogenesis of disease have been by a few established mechanisms. Since the last decade of the 20th century there has been renewed interest in the medical and public media on infectious diseases affecting the cardiovascular and cerebrovascular systems, through their relationship with the development of acceleration of atherosclerosis. This volume highlights and reviews new perspectives of infections on the cardiovascular system as never before. It is a truly valuable resource for scientists, researchers, residents, and fellows in the fields of infectious disease, cardiology, and microbiology.

In the closing decade of the last century, we saw warnings that infectious diseases will require much more attention from patients and physicians in the 21 st century. Recently d- covered diseases such as AIDS pose a major threat to the population at large, and to that threat has been added the re-emergence of established pathogens, microbes that were re- ily treatable in the past. Since infectious diseases already play a major role in the burden of illness and mortality, health care providers and planners are worried. A large proportion of the problem is man-made, arising mainly from the unnecessary overuse of antimicrobials in hospital and community settings and from the agricultural misuse of the agents in animal feed. A consequence has been a dramatic increase in resi- ant strains of bacteria that were considered conquerable several decades ago. Community infections caused by multi-resistant pneumococci serve as an example. These organisms were readily treated with penicillin, but now the spread of penicillin-resistant Streptococcus pneumoniae from continent to continent is becoming a worldwide problem. This is a major concern because pneumococcal infections are common in the community, being the le- ing cause of pneumonia, sinusitis, and meningitis. Resistant bacteria in hospitals are also becoming more prevalent. We have become accustomed to hearing about methicill- resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), but now we have to be concerned about multidrug-resistant coliform bacteria and pseudomonads.

This next volume in the series will provide up to date Information and discussion on future approach to control several challenging Infectious Disease worldwide. The past decade has been highlighted by numerous advances in research of medical scientific knowledge. medical technology and the biological and diagnostic techniques-but somewhat less dramatic changes or improvement in management of medical conditions. This volume will address some of the emerging issues, challenges, and controversies in Infectious Diseases.

This new volume in the series Emerging Infectious Diseases of the 21st Century is a novel book on the role of microbes in the pathogenesis of common and disabling non-infectious diseases. New insights have emerged over the past several years suggesting that our commensal microflora of the gut is extremely important in regulating physiological and immune functions of the body. Covered are the perturbations of the normal composition of our endogenous microbiota, influenced by diet and genetic predispositions, as well as the mechanisms to produce common disorders such as obesity, diabetes, irritable bowel syndrome, colon cancer and atherosclerotic vascular diseases. Also explored is the evidence suggesting that predisposition to increasingly common afflictions such as asthma and multiple sclerosis is influenced, in combination with our genetic composition, by early life exposure to environmental microbes and the time of onset of common viral infections. Chapters provide the most recent information on these disorders with regards to epidemiology, current concepts on pathogenesis and mechanisms of their biology, recent research and data on the role of microbes, analysis of their validity and conclusive remarks and areas for future research.The Role of Microbes in Common Non-Infectious Diseases is an excellent resource for both physicians and investigators from a broad range of disciplines that will help to stimulate new concepts of disease pathogenesis and lead to the unraveling of their mechanisms of diseases and to novel treatments.

This new volume in the series Emerging Infectious Diseases of the 21st Century is a novel book on the role of microbes in the pathogenesis of common and disabling non-infectious diseases. New insights have emerged over the past several years suggesting that our commensal microflora of the gut is extremely important in regulating physiological and immune functions of the body. Covered are the perturbations of the normal composition of our endogenous microbiota, influenced by diet and genetic predispositions, as well as the mechanisms to produce common disorders such as obesity, diabetes, irritable bowel syndrome, colon cancer and atherosclerotic vascular diseases. Also explored is the evidence suggesting that predisposition to increasingly common afflictions such as asthma and multiple sclerosis is influenced, in combination with our genetic composition, by early life exposure to environmental microbes and the time of onset of common viral infections. Chapters provide the most recent information on these disorders with regards to epidemiology, current concepts on pathogenesis and mechanisms of their biology, recent research and data on the role of microbes, analysis of their validity and conclusive remarks and areas for future research.The Role of Microbes in Common Non-Infectious Diseases is an excellent resource for both physicians and investigators from a broad range of disciplines that will help to stimulate new concepts of disease pathogenesis and lead to the unraveling of their mechanisms of diseases and to novel treatments.

A follow-up to Emerging Issues and Controversies in Infectious Diseases, this volume provides a comprehensive review of topical issues in infectious diseases, highlighting the controversies related to the newest findings and recommendations. Coverage includes trends and debates in HIV research, community-acquired pneumonia, H. pylori, progress in Hepatitis C treatment paired with the lack of progress on Hepatitis B, and the effects of climate change on infectious disease epidemiology, among others. This is an essential resource for practicing and academic physicians, investigators, residents, and fellows focused on infectious diseases, infection control, public health, and global health.

A follow-up to Emerging Issues and Controversies in Infectious Diseases, this volume provides a comprehensive review of topical issues in infectious diseases, highlighting the controversies related to the newest findings and recommendations. Coverage includes trends and debates in HIV research, community-acquired pneumonia, H. pylori, progress in Hepatitis C treatment paired with the lack of progress on Hepatitis B, and the effects of climate change on infectious disease epidemiology, among others. This is an essential resource for practicing and academic physicians, investigators, residents, and fellows focused on infectious diseases, infection control, public health, and global health.

This is a timely and essential companion to the recently published Antimicrobial Resistance in the 21st Century, Second Edition. Antimicrobial resistance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO's top priorities, but in 2017, it conceded that the current drug development pipeline was insufficient to mitigate the threat. This book discusses recent progress and bolster new agent discovery and development, by providing researchers and students who will soon enter the field with a thorough guide to the advancements made in the last decade. Coverage includes new systemic antimicrobials approved since 2010, with detailed analysis of antibiotics, antivirals, antifungals, and antiparasitics, as well as agents in development for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparison. This volume is designed for researchers and students of infectious disease and medical microbiology, as well as clinicians in need of a comprehensive guide to newly developed agents.

This is a timely and essential companion to the recently published Antimicrobial Resistance in the 21st Century, Second Edition. Antimicrobial resistance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO's top priorities, but in 2017, it conceded that the current drug development pipeline was insufficient to mitigate the threat. This book discusses recent progress and bolster new agent discovery and development, by providing researchers and students who will soon enter the field with a thorough guide to the advancements made in the last decade. Coverage includes new systemic antimicrobials approved since 2010, with detailed analysis of antibiotics, antivirals, antifungals, and antiparasitics, as well as agents in development for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparison. This volume is designed for researchers and students of infectious disease and medical microbiology, as well as clinicians in need of a comprehensive guide to newly developed agents.

The book begins with a review of zoonotic pandemics of the past: the “Black Death” or bubonic plague of the Middle Ages, the Spanish Influenza pandemic (derived from avian influenza) of the early 20th century, to the more modern pandemic of AIDS/HIV infection, which originated in Africa from primates. However, the majority of chapters focus on more recent zoonoses, which have been recognized since the late 20th century to the present: · SARS and MERS coronaviruses· New avian influenza viruses · The tick-borne Henan fever virus from China· The tick-borne Heartland virus from the United States · Recently recognized bacterial pathogens, such as Streptococcus suis from pigs. In addition, reemergence of established zoonoses that have expanded their niche are reviewed, such as the spread of Zika virus and Chikungunya virus to the Western Hemisphere, and the emergence and spread of Ebola virus infection in Africa. A chapter is also devoted to an overview of the mechanisms and various types of animals involved in the transmission of diseases to humans, and the potential means of control and prevention. Many endemic and sporadic diseases are still transmitted by animals, through either direct or indirect contact, and zoonoses are estimated to account for about 75% of all new and emerging infectious diseases. It is predicted by public health experts that the next major pandemic of infectious disease will be of animal origin, making Emerging Zoonoses: A Worldwide Perspective a crucial resource to all health care specialists by providing them with much needed information on these zoonotic diseases.iv>

Antimicrobial resistance is now a general problem. Many of us have elderly relatives who died from a drug-resistant infection, and some of us have suffered from a resistant urinary infection that likely came from intestinal bacteria following antibiotic consumption. Antimicrobial Resistance in the 21st Century provides a broad introduction to the subject in which the situation with problematic pathogens is detailed, the biology of resistance is described, and gaining approval for new antibiotics is discussed. Some topics are immediately practical, such as watching for resistant pathogen sub-populations in cultures taken from patients; other topics point to future research efforts that may lead to new antimicrobials and ways to stimulate the action of existing ones. Overall, Antimicrobial Resistance in the 21st Century provides an update for physicians, serves as a starting point for graduate students interested in solving the resistance problem, and may serve as a text for a course on resistance. Lay readers familiar with microbiology will gain an appreciation for a medical issue that promises to be one of the most important of our time. Ignatius Fong, Department of Medicine, University of Toronto Series Editor – Emerging Infectious Diseases of the 21st Century David Shlaes, Founder, Anti-Infectives Consulting Editor – Antimicrobial Agents and ChemotherapyKarl Drlica, The Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey